Noninvasive intranasal stem cells bypass the blood-brain barrier to target the brain to treat Parkinson's disease, stroke, MS, brain tumors, cerebral ischemia, Alzheimer's and other CNS disorders

Together with my collaborators in Germany, especially Lusine Danielyan M.D., we discovered and patented that therapeutic cells, including adult stem cells and genetically-engineered cells, can be non-invasively delivered to the CNS using the noninvasive intranasal delivery method that I developed. The first of our scientific papers on this new discovery describes this successful method of delivery and proprietary formulations that enhance delivery.  The second of our papers describes the successful treatment of Parkinson's disease in an animal model with intranasal adult bone marrow derived mesenchymal stem cells. Journal of Nature and Science, 1(1):e23, 2015.